Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKinsey
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Last Updated: March 27, 2023

Drug Price Trends for RIFABUTIN


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drug Price Trends for RIFABUTIN

Best Wholesale Price for RIFABUTIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RIFABUTIN 150MG CAP Marlex Pharmaceuticals, Inc. 10135-0738-01 100 464.24 4.64240 EACH 2022-06-01 - 2024-05-31 FSS
RIFABUTIN 150MG CAP Greenstone, LLC 59762-1350-01 100 493.51 2023-01-01 - 2023-08-31 Big4
RIFABUTIN 150MG CAP Greenstone, LLC 59762-1350-01 100 1143.10 2023-01-01 - 2023-08-31 FSS
MYCOBUTIN 150MG CAP Pfizer, Inc. DBA Pfizer 00013-5301-17 100 253.87 2023-01-01 - 2023-06-30 Big4
MYCOBUTIN 150MG CAP Pfizer, Inc. DBA Pfizer 00013-5301-17 100 1245.11 2023-01-01 - 2023-06-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or Try a Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Baxter
Medtronic
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2023 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
 NCE-1 Patent Challenge Dates 2023 - 2024
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group